NCMRR Early Career Research Award (R03 Clinical Trial Optional) | PAR 23 029

Opportunity Information: Apply for PAR 23 029

The NCMRR Early Career Research Award (R03 Clinical Trial Optional), Funding Opportunity Number PAR 23 029, is a National Institutes of Health discretionary grant designed to help early career rehabilitation scientists launch independent research programs. It supports both basic and clinical rehabilitation research, and projects must align with one or more areas within the mission of the National Center for Medical Rehabilitation Research (NCMRR). Applicants are encouraged to use the NIH Research Plan on Rehabilitation as a guide for identifying priority topics and shaping their project around current strategic directions in rehabilitation research.

This opportunity uses the NIH R03 mechanism, which is meant for smaller, focused studies that can be completed with a limited scope and budget compared with larger NIH awards. The program is intentionally flexible about the kinds of studies it will fund, as long as they are clearly relevant to medical rehabilitation. Examples of supported project types include secondary analyses of existing datasets, small and self-contained research projects, development or refinement of research methods, translational research efforts that help move discoveries toward practical use, outcomes research aimed at measuring real-world impacts of rehabilitation approaches, and development of new rehabilitation technologies. Clinical trials are optional under this announcement, meaning applicants may propose a clinical trial if it fits their aims, but a clinical trial is not required.

The core purpose of the award is career-building through evidence generation. Regardless of the specific research approach, the main expectation is that the project will produce strong preliminary data that positions the Program Director(s)/Principal Investigator(s) to submit a competitive R01 application afterward. In practical terms, the R03 is meant to help an early career investigator demonstrate feasibility, generate pilot findings, validate measures or methods, or establish early proof-of-concept results that can justify a larger-scale study later.

Eligibility is broad and includes many organization types that commonly apply for NIH funding. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (outside higher education); for-profit organizations other than small businesses; small businesses; and other entities. The announcement also explicitly notes additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. (foreign) organizations.

From an administrative standpoint, the opportunity is listed under CFDA 93.865, with the NIH as the issuing agency. The original closing date shown is 2026-05-08. The publicly provided summary does not specify an award ceiling or the expected number of awards in the excerpted source data, so applicants typically need to consult the full funding announcement and NIH policy guidance for the most current budget and project period limits associated with the R03 mechanism.

• The National Institutes of Health in the health, income security and social services sector is offering a public funding opportunity titled "NCMRR Early Career Research Award (R03 Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.865.
• This funding opportunity was created on 2022-10-17.
• Applicants must submit their applications by 2026-05-08. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 23 029

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: